These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 18782775

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation.
    Cunha SR, Hund TJ, Hashemi S, Voigt N, Li N, Wright P, Koval O, Li J, Gudmundsson H, Gumina RJ, Karck M, Schott JJ, Probst V, Le Marec H, Anderson ME, Dobrev D, Wehrens XH, Mohler PJ.
    Circulation; 2011 Sep 13; 124(11):1212-22. PubMed ID: 21859974
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway.
    Ackermann MA, King B, Lieberman NAP, Bobbili PJ, Rudloff M, Berndsen CE, Wright NT, Hecker PA, Kontrogianni-Konstantopoulos A.
    J Mol Cell Cardiol; 2017 Oct 13; 111():27-39. PubMed ID: 28826662
    [Abstract] [Full Text] [Related]

  • 25. Molecular evolution of ankyrin: gain of function in vertebrates by acquisition of an obscurin/titin-binding-related domain.
    Hopitzan AA, Baines AJ, Kordeli E.
    Mol Biol Evol; 2006 Jan 13; 23(1):46-55. PubMed ID: 16135777
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Identification, tissue expression and chromosomal localization of human Obscurin-MLCK, a member of the titin and Dbl families of myosin light chain kinases.
    Russell MW, Raeker MO, Korytkowski KA, Sonneman KJ.
    Gene; 2002 Jan 09; 282(1-2):237-46. PubMed ID: 11814696
    [Abstract] [Full Text] [Related]

  • 28. Exercise-induced alterations and loss of sarcomeric M-line organization in the diaphragm muscle of obscurin knockout mice.
    Randazzo D, Blaauw B, Paolini C, Pierantozzi E, Spinozzi S, Lange S, Chen J, Protasi F, Reggiani C, Sorrentino V.
    Am J Physiol Cell Physiol; 2017 Jan 01; 312(1):C16-C28. PubMed ID: 27784675
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Obscurins: Goliaths and Davids take over non-muscle tissues.
    Ackermann MA, Shriver M, Perry NA, Hu LY, Kontrogianni-Konstantopoulos A.
    PLoS One; 2014 Jan 01; 9(2):e88162. PubMed ID: 24516603
    [Abstract] [Full Text] [Related]

  • 31. Novel interactions of ankyrins-G at the costameres: the muscle-specific Obscurin/Titin-Binding-related Domain (OTBD) binds plectin and filamin C.
    Maiweilidan Y, Klauza I, Kordeli E.
    Exp Cell Res; 2011 Apr 01; 317(6):724-36. PubMed ID: 21223964
    [Abstract] [Full Text] [Related]

  • 32. Ankyrin-B regulates Kir6.2 membrane expression and function in heart.
    Li J, Kline CF, Hund TJ, Anderson ME, Mohler PJ.
    J Biol Chem; 2010 Sep 10; 285(37):28723-30. PubMed ID: 20610380
    [Abstract] [Full Text] [Related]

  • 33. The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes.
    Mohler PJ, Gramolini AO, Bennett V.
    J Biol Chem; 2002 Mar 22; 277(12):10599-607. PubMed ID: 11781319
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Interactions with titin and myomesin target obscurin and obscurin-like 1 to the M-band: implications for hereditary myopathies.
    Fukuzawa A, Lange S, Holt M, Vihola A, Carmignac V, Ferreiro A, Udd B, Gautel M.
    J Cell Sci; 2008 Jun 01; 121(11):1841-51. PubMed ID: 18477606
    [Abstract] [Full Text] [Related]

  • 37. The kinase domains of obscurin interact with intercellular adhesion proteins.
    Hu LY, Kontrogianni-Konstantopoulos A.
    FASEB J; 2013 May 01; 27(5):2001-12. PubMed ID: 23392350
    [Abstract] [Full Text] [Related]

  • 38. Developmental expression and differential cellular localization of obscurin and obscurin-associated kinase in cardiac muscle cells.
    Borisov AB, Raeker MO, Russell MW.
    J Cell Biochem; 2008 Apr 01; 103(5):1621-35. PubMed ID: 18041765
    [Abstract] [Full Text] [Related]

  • 39. Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes.
    Mohler PJ, Rivolta I, Napolitano C, LeMaillet G, Lambert S, Priori SG, Bennett V.
    Proc Natl Acad Sci U S A; 2004 Dec 14; 101(50):17533-8. PubMed ID: 15579534
    [Abstract] [Full Text] [Related]

  • 40. Ankyrin-B targets beta2-spectrin to an intracellular compartment in neonatal cardiomyocytes.
    Mohler PJ, Yoon W, Bennett V.
    J Biol Chem; 2004 Sep 17; 279(38):40185-93. PubMed ID: 15262991
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.